Oncolytic viruses (OVs) are potential antitumor agents with unique therapeutic mechanisms.
They possess the ability of direct oncolysis and the induction of antitumor immunity. OV can …

Oncolytic viruses (OVs), viruses that specifically result in killing tumor cells, represent a
promising class of cancer therapy. Recently, the focus in the OV therapy field has shifted …

Oncolytic viruses (OVs) can selectively kill tumor cells without affecting normal cells, as well
as activate the innate and adaptive immune systems in patients. Thus, they have been …

Cancer Immunotherapy relies on harnessing a patient's immune system to fine-tune specific
anti-tumor responses and ultimately eradicate cancer. Among diverse therapeutic …

Oncolytic viruses (OVs) have been gaining attention in the pharmaceutical industry as a
novel immunotherapeutic and therapeutic adjuvant due to their ability to induce and boost …

Tumor cells manipulate the local environment in which they grow, creating a tumor
microenvironment (TME) that promotes tumor survival and metastasis. The TME is an …

Oncolytic virus (OV) is a new therapeutic strategy for cancer treatment. OVs can selectively
infect and destroy cancer cells, and therefore act as an in situ cancer vaccine by releasing …

Simple Summary Oncolytic viruses (OVs) are viruses that selectively target and kill cancer
cells while sparing normal ones. OVs are from diverse families of viruses, but naturally …

Oncolytic viral therapy is a new promising strategy against cancer. Oncolytic viruses (OVs)
can replicate in cancer cells but not in normal cells, leading to lysis of the tumor mass …

Oncolytic viruses (OVs) not only kill cancer cells by direct lysis but also generate a significant
anti-tumor immune response that allows for prolonged cancer control and in some cases …